Aridis Pharmaceuticals (ARDS)

Last Closing Price: 0.31 (2023-07-18)

Cost of Goods Sold (Quarterly)

Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.

Aridis Pharmaceuticals (ARDS) Cost of Goods Sold data is not available.

Figures for fiscal quarter ending 2023-09-30
Income Statement Financials
$0.42M
$-0.08M
Cost of Goods Sold
--
$0.42M
$1.29M
$-0.87M
$0.79M
$-0.08M
$-0.08M
$-0.08M
$-0.08M
$-0.08M
$-0.08M
$-0.87M
$-0.81M
37.43M
37.43M
$0.00
$0.00
Balance Sheet Financials
$4.11M
$0.51M
$2.42M
$6.53M
$17.48M
--
$0.85M
$18.34M
$-11.80M
$-11.81M
$-11.80M
44.57M
Cash Flow Statement Financials
$-9.33M
$0.01M
$4.29M
$5.56M
$0.54M
$-5.02M
$0.66M
--
--
Fundamental Metrics & Ratios
0.24
--
--
--
-0.29
100.00%
-208.39%
-208.39%
--
-19.90%
-19.90%
$-9.31M
--
--
--
0.06
--
0.81
111.58
0.70%
0.70%
-1.27%
0.70%
$-0.26
$-0.25
$-0.25